T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments

por Daver, Naval, Alotaibi, Ahmad S., Bücklein, Veit, Subklewe, Marion
Publicado 2021

The knowledge about coronavirus (COVID-19) among populations in two different Arab countries

por Doumani, Mazen, Habib, Adnan Asaad, Alotaibi, Ahmad Noor, Alharbi, Abdulaziz Saeed, Alduraibi, Mohammed Sulaiman, Otain, Osama Abdullah, Shbib, Moumena, Sahari, Sobhi Maher
Publicado 2020

The prevalence of pulmonary embolism among COVID-19 patients underwent CT pulmonary angiography

por Kajoak, Samih, Osman, Hamid, Elnour, Hanan, Elzaki, Amin, Alghamdi, Ahmad Joman, Elhaj, Mona, Alotaibi, Ahmad, Alboqami, Khaled, Alturaiki, Fahad, Alsulaimani, Ali, Alsulimany, Kholoud, Khandaker, Mayeen Udinn, Alamri, Sultan, Alzamil, Yasser
Publicado 2022

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series

por Alotaibi, Ahmad S., Yilmaz, Musa, Loghavi, Sanam, DiNardo, Courtney, Borthakur, Gautam, Kadia, Tapan M., Thakral, Beenu, Pemmaraju, Naveen, Issa, Ghayas C., Konopleva, Marina, Short, Nicholas J., Patel, Keyur, Tang, Guilin, Ravandi, Farhad, Daver, Naval
Publicado 2020

Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol – a retrospective analysis of...

por Hanbali, Amr, Kotb, Ahmed, Fakih, Riad El, Alfraih, Feras, Ahmed, Syed Osman, Shaheen, Marwan, Alhayli, Saud, Alahmari, Ali, Alotaibi, Ahmad, Alshaibani, Alfadel, Riash, Mahmoud Abu, Deeba, Farah, Asif, Maryam, Rasheed, Walid, Alzahrani, Hazzaa, Alsharif, Fahad, Chaudhri, Naeem, Almohareb, Fahad, Aljurf, Mahmoud
Publicado 2021

Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia

por Hanbali, Amr, Kotb, Ahmed, Fakih, Riad El, Alfraih, Feras, Shihata, Nahla, Rasheed, Walid, Ahmed, Syed Osman, Shaheen, Marwan, Alhayli, Saud, Alahmari, Ali, Alotaibi, Ahmad, Alshaibani, Alfadel, Albabtain, Abdulwahab, Alfayez, Mansour, Hassan, Maha, Alsharif, Fahad, Chaudhri, Naeem, Almohareb, Fahad, Alzahrani, Hazzaa, Aljurf, Mahmoud
Publicado 2023

Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML

por Yilmaz, Musa, Alfayez, Mansour, DiNardo, Courtney D., Borthakur, Gautam, Kadia, Tapan M., Konopleva, Marina Y., Loghavi, Sanam, Kanagal-Shamanna, Rashmi, Patel, Keyur P., Jabbour, Elias J., Garcia-Manero, Guillermo, Pemmaraju, Naveen, Pierce, Sherry A., Ghayas, Issa, Short, Nicholas J., Montalban-Bravo, Guillermo, Takahashi, Koichi, Assi, Rita, Alotaibi, Ahmad S., Ohanian, Maro, Andreeff, Michael, Cortes, Jorge E., Kantarjian, Hagop M., Ravandi, Farhad, Daver, Naval G.
Publicado 2020

Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML

por Yilmaz, Musa, Alfayez, Mansour, DiNardo, Courtney D., Borthakur, Gautam, Kadia, Tapan M., Konopleva, Marina Y., Loghavi, Sanam, Kanagal-Shamanna, Rashmi, Patel, Keyur P., Jabbour, Elias J., Garcia‑Manero, Guillermo, Pemmaraju, Naveen, Pierce, Sherry A., Ghayas, Issa, Short, Nicholas J., Montalban-Bravo, Guillermo, Takahashi, Koichi, Assi, Rita, Alotaibi, Ahmad S., Ohanian, Maro, Andreeff, Michael, Cortes, Jorge E., Kantarjian, Hagop M., Ravandi, Farhad, Daver, Naval G.
Publicado 2021

P1420: COMPARATIVE STUDY OF CYCLOSPORINE VERSUS TACROLIMUS IN ADDITION TO METHOTREXATE AS GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN MATCHED SIBLING ALLOGENEIC STEM CELL TRANSPLANTAT...

por Alfaqawi, Samar, Mohammed Saleh, Mostafa, Kotb, Ahmed, Abdallah, Ghada, Ali, Leena, Alasbali, Reem, Hussain, Taimor, Alfadhil, Haroon, Bin Salman, Ahmed, Nassani, Momen, Baujaifer, Yazeed, Sharif, Mohammed I., Nassar, Marwa, Samarkandi, Sarah, Madien, Heba, Hejab, Amal, Alyamany, Ruah, Alnughmush, Ahmed, Alamer, Abdullah, Saad, Ayman, Alfayez, Mansour, Albabtain, Abdelwahab, Alshaibani, Alfadel, Alotaibi, Ahmad, Alhayli, Saud, Shaheen, Marwan, Ahmed, Syed O., Elfakih, Riad, Hanbali, Amr, Alfraih, Feras, Rasheed, Walid, Alsharif, Fahad, Chaudhri, Naeem, Alzahrani, Hazza, Almohareb, Fahad, Aljurf, Mahmoud, Alahmari, Ali
Publicado 2023